We are live on ! Find out more
DCP

DSM Capital Partners Portfolio holdings

AUM $5.66B
1-Year Est. Return 27.45%
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+27.45%
3 Year Est. Return
+126.04%
5 Year Est. Return
+156.94%
10 Year Est. Return
+722.36%
AUM
$6.86B
AUM Growth
+$75.5M
Cap. Flow
-$294M
Cap. Flow %
-4.28%
Top 10 Hldgs %
64.69%
Holding
57
New
4
Increased
18
Reduced
24
Closed
6

Top Sells

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$160M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$154M
3
V icon
Visa
V
+$112M
4
ABT icon
Abbott
ABT
+$72.5M
5
CP icon
Canadian Pacific Kansas City
CP
+$69.2M

Sector Composition

Rank Sector Weight
1 Technology 27.55%
2 Consumer Discretionary 18.03%
3 Financials 15.82%
4 Communication Services 14.88%
5 Healthcare 12.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMO icon
51
Bank of Montreal
BMO
$126B
-16,150
Closed -$1.21M
REGN icon
52
Regeneron Pharmaceuticals
REGN
$72.1B
-374,203
Closed -$154M
SCHW
53
Charles Schwab
SCHW
$184B
-8,124
Closed -$347K
SYK icon
54
Stryker
SYK
$133B
-4,600
Closed -$909K
TD icon
55
Toronto Dominion Bank
TD
$199B
-49,950
Closed -$2.71M

Similar funds

DSM Capital Partners's Q2 2019 Portfolio in Review

As of Q2 2019, DSM Capital Partners held 57 positions worth $6.86B, up 1.1% from $6.78B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

DSM Capital Partners withdrew a net $294M in Q2 2019, closing 6 positions and reducing 24 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $154M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, DSM Capital Partners opened a new position in Palo Alto Networks worth $129M.

  • DSM Capital Partners's largest Q2 2019 buy was Palo Alto Networks: 3,800,910 shares worth $129M.
  • DSM Capital Partners added most to Amazon in Q2 2019, an estimated $115M increase.
  • DSM Capital Partners's biggest Q2 2019 reduction was MSCI, cutting an estimated $160M.
  • DSM Capital Partners fully exited Regeneron Pharmaceuticals in Q2 2019, selling an estimated $154M.
  • DSM Capital Partners's ten largest holdings make up 65% of its $6.86B portfolio in Q2 2019.
  • DSM Capital Partners opened 4 new positions and closed 6 in Q2 2019.
  • DSM Capital Partners's portfolio value rose 1.1% quarter-over-quarter to $6.86B.

Based on DSM Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.